Bioventus (BVS) - 2023 Q4 - Annual Report

SECURITIES AND EXCHANGE COMMISSION ________________ ________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-37844 (Exact Name of Registrant as Specified in Its Charter) | --- | |-----------------------------| | | | | | Accelera ...